Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Cagrilintide: Long-acting amylin analog explained What cagrilintide is: Synthetic analog of human amylin hormone Also called "pramlintide long-acting" (related compound) Developed by Novo Nordisk Currently investigational (Phase 3 trials) Not yet FDA approved (as of 2024) Weekly subcutaneous injection Natural amylin background: Peptide hormone co-secreted with insulin Made by pancreatic beta cells Released after meals in response to nutrients Important satiety signal Regulates postprandial glucose Deficient in diabetes Why synthetic cagrilintide was developed: Natural amylin very short half-life (minutes) Impractical for treatment Cagrilintide engineered for long duration Weekly dosing vs multiple daily injections Better pharmacokinetics Enhanced stability Learn about peptides , how peptides work , and what are peptides used for at SeekPeptides
It is important to follow dosing and safety instructions when administering any type of injection, including IM injections
Our guide on affordable tirzepatide options covers how these billing pathways affect out-of-pocket costs
Es esencial consultar con profesionales de la salud para obtener una gua personalizada
